ClearPoint Neuro, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
ClearPoint Neuro, Inc. (CLPT) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $3.27 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-08-03
- ClearPoint Neuro, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2026-03-31 was $3.83, a 51.64% decline year-over-year.
- ClearPoint Neuro, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2025-03-31 was $7.92, a 188.00% increase year-over-year.
- ClearPoint Neuro, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2024-03-31 was $2.75.
- ClearPoint Neuro, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2022-03-31 was $2.60, a 0.00% change year-over-year.
- ClearPoint Neuro, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2025 was $5.98, a 14.78% increase from fiscal 2024.
- ClearPoint Neuro, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $5.21, a 186.26% increase from fiscal 2023.
- ClearPoint Neuro, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $1.82, a 25.71% decline from fiscal 2022.
- ClearPoint Neuro, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2022 was $2.45, a 8.58% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.27 10-Q · filed 2026-08-03 | |||
| 2026-03-31 | $3.83 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | $5.98 10-K · filed 2026-03-17 | |||
| 2025-09-30 | $6.64 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | $6.86 10-Q · filed 2025-08-12 | |||
| 2025-03-31 | $7.92 10-Q · filed 2025-05-13 | |||
| 2024-12-31 | $5.21 10-K · filed 2025-02-26 | |||
| 2024-09-30 | $2.89 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | $3.01 10-Q · filed 2024-08-07 | |||
| 2024-03-31 | $2.75 10-Q · filed 2024-05-07 | |||
| 2023-12-31 | $1.82 10-K · filed 2024-03-12 | |||
| 2023-09-30 | $1.82 10-Q · filed 2023-11-09 | |||
| 2022-12-31 | $2.45 10-K · filed 2023-03-01 | |||
| 2022-09-30 | $2.36 10-Q · filed 2022-11-08 | |||
| 2022-06-30 | $2.60 10-Q · filed 2022-08-10 | |||
| 2022-03-31 | $2.60 10-Q · filed 2022-05-11 | |||
| 2021-12-31 | $2.68 10-K · filed 2022-03-09 | |||
| 2021-09-30 | $2.69 10-Q · filed 2021-11-10 | |||
| 2021-06-30 | $2.59 10-Q · filed 2021-08-12 | |||
| 2021-03-31 | $2.60 10-Q · filed 2021-05-11 | |||
| 2020-12-31 | $2.47 10-K · filed 2021-03-22 | |||
| 2020-09-30 | $1.74 10-Q · filed 2020-11-12 | |||
| 2020-06-30 | $1.74 10-Q · filed 2020-08-13 | |||
| 2019-12-31 | $1.89 10-K · filed 2021-03-22 | |||
| 2019-09-30 | $1.74 10-Q · filed 2019-11-13 | |||
| 2014-12-31 | $0.88 10-K · filed 2016-03-25 | |||
| 2014-09-30 | $0.88 10-Q · filed 2014-11-14 | |||
| 2014-06-30 | $0.88 10-Q · filed 2014-08-11 | |||
| 2014-03-31 | $0.88 10-Q · filed 2014-05-13 | |||
| 2012-12-31 | $1.80 10-K · filed 2014-03-28 | |||
| 2012-09-30 | $1.80 10-Q · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |